Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Review Article


Article page

69-72


Authors Details

Saba Khan*, Mohd Anas Shaikh, Altamash Shaikh, Mohammad Wais


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 473

PDF Downloaded: 229


Moyamoya – A progressive disorder an update and review


Review Article

Author Details : Saba Khan*, Mohd Anas Shaikh, Altamash Shaikh, Mohammad Wais

Volume : 10, Issue : 2, Year : 2023

Article Page : 69-72

https://doi.org/10.18231/j.ijpp.2023.027



Suggest article by email

Get Permission

Abstract

There is stenosis or narrowing of the internal carotid artery in Moyamoya disease, a relatively rare kind of neurological condition. This may result in illnesses like ischemia, haemorrhage, or even a potentially fatal stroke. It is still unclear what this disease's specific pathogenesis is understood. The Moyamoya disease has a total of six stages. Scientists have not yet developed a drug that can fully treat moyamoya disease because it is such a rare disorder. Surgery is the only approach that works here. But once more, this won't help with finishing the course of treatment. It will only aid in slowing the spread of the disease.


Keywords: Moyamoya, Cerebrovascular disease, Neurological


How to cite : Khan S, Shaikh M A, Shaikh A, Wais M, Moyamoya – A progressive disorder an update and review. Indian J Pharm Pharmacol 2023;10(2):69-72

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.